Literature DB >> 16098279

Anticonvulsants in anxiety disorders.

Gustavo Kinrys1, Lisa E Wygant.   

Abstract

Anticonvulsant drugs have shown promising results in the treatment of mood disorders, leading to the investigation of their potential efficacy in other psychiatric disorders. Numerous case reports, open-label trials, and placebo- controlled trials investigating the use of anticonvulsants in the treatment of anxiety disorders have yielded broad and varying results. Generally, these studies have indicated a potential role for anticonvulsants in the treatment of anxiety as monotherapy or augmentation therapy; however, these early findings must be supported by additional investigation in large-scale, placebo-controlled studies. This article reviews past and current research being done in this novel area of psychopharmacology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098279     DOI: 10.1007/s11920-005-0079-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  51 in total

1.  Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.

Authors:  T C Kumar; S Khanna
Journal:  Aust N Z J Psychiatry       Date:  2000-06       Impact factor: 5.744

2.  Valproate therapy for chronic, combat-induced posttraumatic stress disorder.

Authors:  Frederick Petty; Lori L Davis; Alexandria L Nugent; Gerald L Kramer; Andra Teten; Andrew Schmitt; Robert C Stone
Journal:  J Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.153

3.  Psychopharmacology of anticonvulsants: do all anticonvulsants have the same mechanism of action?

Authors:  Stephen M Stahl
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

4.  Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder.

Authors:  G Corá-Locatelli; B D Greenberg; J Martin; D L Murphy
Journal:  J Clin Psychiatry       Date:  1998-09       Impact factor: 4.384

5.  Treatment of social phobia with gabapentin: a placebo-controlled study.

Authors:  A C Pande; J R Davidson; J W Jefferson; C A Janney; D J Katzelnick; R H Weisler; J H Greist; S M Sutherland
Journal:  J Clin Psychopharmacol       Date:  1999-08       Impact factor: 3.153

6.  Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy.

Authors:  M B Hamner; P S Brodrick; L A Labbate
Journal:  Ann Clin Psychiatry       Date:  2001-09       Impact factor: 1.567

7.  Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

Authors:  Atul C Pande; Jerri G Crockatt; Douglas E Feltner; Carol A Janney; Ward T Smith; Richard Weisler; Peter D Londborg; Robert J Bielski; Dan L Zimbroff; Jonathan R T Davidson; Maria Liu-Dumaw
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

8.  An open trial of topiramate in the treatment of generalized social phobia.

Authors:  Michael Van Ameringen; Catherine Mancini; Beth Pipe; Jonathan Oakman; Mark Bennett
Journal:  J Clin Psychiatry       Date:  2004-12       Impact factor: 4.384

9.  Tiagabine for posttraumatic stress disorder: a case series of 7 women.

Authors:  Fletcher B Taylor
Journal:  J Clin Psychiatry       Date:  2003-12       Impact factor: 4.384

10.  An open-label study of levetiracetam for the treatment of social anxiety disorder.

Authors:  Naomi M Simon; John J Worthington; Alicia C Doyle; Elizabeth A Hoge; Gustavo Kinrys; Diana Fischmann; Nathaniel Link; Mark H Pollack
Journal:  J Clin Psychiatry       Date:  2004-09       Impact factor: 4.384

View more
  2 in total

1.  Structural and functional neuroimaging studies in generalized anxiety disorder: a systematic review.

Authors:  Domenico Madonna; Giuseppe Delvecchio; Jair C Soares; Paolo Brambilla
Journal:  Braz J Psychiatry       Date:  2019-05-16       Impact factor: 2.697

2.  The Therapeutic Effects of Low-Frequency Electrical Stimulations Adjunct to Sodium Valproate on Seizure and Behaviors.

Authors:  Raha Zalkhani; Ahmad Ali Moazedi; Zohreh Ghotbeddin; Mahdi Pourmahdi Borujeni
Journal:  Basic Clin Neurosci       Date:  2020-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.